Evidence map›Paper›PMID 41848314›Full record

ArticleMicrobiology spectrum2026

Non-susceptibility of

Yinting Xing, Jingjia Zhang, Long Sun, Ning Li, Huizi Wang, Yanling Zhang, Xinmiao Jia, Hongli Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yinting XingDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0001-6900-8658
Jingjia ZhangDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Beijing, China.ORCID 0009-0002-3791-1580
Long SunDepartment of Clinical Laboratory, Hangzhou Women's Hospital, Hangzhou Maternity and Child Health Care Hospital, Hangzhou, China.ORCID 0009-0003-7140-8230
Ning LiDepartment of Laboratory Medicine, Luohe Central Hospital, Luohe, China.
Huizi WangDepartment of Laboratory Medicine, Jilin Central Hospital, Jilin, China.
Yanling ZhangDepartment of Laboratory Medicine, Ordos Central Hospital, Ordos, China.
Xinmiao JiaCenter for bioinformatics, National Infrastructures for Translational Medicine, Institute of Clinical Medicine & Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID 0000-0002-6084-0146
Hongli SunDepartment of Laboratory Medicine, Peking Union Medical College Hospital, Beijing, China.ORCID 0000-0003-4656-2124

Funding

National key Research Program of China 2021YFC2302000the fundamental research funds for the provincial universities in Heilongjiang province 2024-KYYWF-0201
6 · The paper itself

Abstract

We aimed to assess the comparability of daptomycin (DAP) antimicrobial susceptibility testing (AST) for IMPORTANCE: The overall CA of AST results for DAP between VITEK-2 and BMD was 28.4%, with an EA of 20.2%. In the DAP-sensitive group, CA was 100%, but in the DAP-nonsensitive group, VITEK-2 misclassified 7.4% of sensitive isolates as resistant and 92.2% as intermediate. The consistency between VITEK-2 and BMD decreased significantly as the VITEK-2 MIC value increased. No significant correlation was found between VITEK-2 results and Ca

Indexed as

Anti-Bacterial AgentsDaptomycinEnterococcus faecalisGram-Positive Bacterial InfectionsDrug Resistance, BacterialFemaleHumansMaleMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsDaptomycinantimicrobial susceptibility testingbroth microdilutiondaptomycindaptomycin-nonsusceptible EnterococcusEnterococcus faecalis

Identifiers

PMID41848314
PMCPMC13055359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.